2003
DOI: 10.1073/pnas.2034201100
|View full text |Cite
|
Sign up to set email alerts
|

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

Abstract: Leukemia can be viewed as a newly formed, abnormal hematopoietic tissue initiated by a few leukemic stem cells (LSCs) that undergo an aberrant and poorly regulated process of organogenesis analogous to that of normal hematopoietic stem cells. A hallmark of all cancers is the capacity for unlimited self-renewal, which is also a defining characteristic of normal stem cells. Given this shared attribute, it has been proposed that leukemias may be initiated by transforming events that take place in hematopoietic st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
458
0
14

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 582 publications
(480 citation statements)
references
References 104 publications
6
458
0
14
Order By: Relevance
“…They are similar to stem cells and are capable of both self-renewal and differentiation into all of the cells within a tumor (Siclari and Qin, 2010;Rangwala et al, 2011). CSCs have been identified in a number of cancers including acute myeloid leukaemia (AML) (Bonnet and Dick, 1997;Passegue et al, 2003), glioblastoma (Singh et al, 2003), breast (Al-Hajj et al, 2003;Ponti et al, 2005), lung (Kim et al, 2005), prostate (Collins et al, 2005), ovarian (Bapat et al, 2005), gastric (Houghton et al, 2004), esophagous ( Li et al, 2013 ), Head and Neck SCC (Satpute et al, 2013) and skin cancers (Frank et al, 2005;Monzani et al, 2007). Different markers have been identified to be expressed on melanoma stem cells (Quintana et al, 2010;Shakhova and Sommer, 2013) comprising CD20 (Fang et al, 2005) and ABC transporter family members such as MDR1, ABCG2 and ABCB5 (Frank et al, 2003;Frank et al, 2005;Monzani et al, 2007;Keshet et al, 2008;Schatton et al, 2008), CD271 (Boiko et al, 2010;Civenni et al, 2011), CD44 (Fernandez-Figueras et al, 1996, CD133 (Klein et al, 2006) and Nestin (Piras et al, 2010;Fusi et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…They are similar to stem cells and are capable of both self-renewal and differentiation into all of the cells within a tumor (Siclari and Qin, 2010;Rangwala et al, 2011). CSCs have been identified in a number of cancers including acute myeloid leukaemia (AML) (Bonnet and Dick, 1997;Passegue et al, 2003), glioblastoma (Singh et al, 2003), breast (Al-Hajj et al, 2003;Ponti et al, 2005), lung (Kim et al, 2005), prostate (Collins et al, 2005), ovarian (Bapat et al, 2005), gastric (Houghton et al, 2004), esophagous ( Li et al, 2013 ), Head and Neck SCC (Satpute et al, 2013) and skin cancers (Frank et al, 2005;Monzani et al, 2007). Different markers have been identified to be expressed on melanoma stem cells (Quintana et al, 2010;Shakhova and Sommer, 2013) comprising CD20 (Fang et al, 2005) and ABC transporter family members such as MDR1, ABCG2 and ABCB5 (Frank et al, 2003;Frank et al, 2005;Monzani et al, 2007;Keshet et al, 2008;Schatton et al, 2008), CD271 (Boiko et al, 2010;Civenni et al, 2011), CD44 (Fernandez-Figueras et al, 1996, CD133 (Klein et al, 2006) and Nestin (Piras et al, 2010;Fusi et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…2 It has been found that mutations occurring during expansion phases of totipotential stem cells throughout development may prompt the formation of tumors in adulthood. In mature adult tissues, stem cells and progenitor cells may also constitute the sources of oncogenic transformation following somatic mutations, as shown by the isolation of TSCs from human acute myeloid leukemia (AML) [3][4][5][6] and breast cancer. [7][8][9] In tumors of the central nervous system (CNS), TSCs have also been isolated and successfully maintained in culture from medulloblastoma, 10 glioblastoma, [11][12][13][14][15][16][17][18] and ependymoma, 19 as well as from several glioma cell lines.…”
mentioning
confidence: 99%
“…4 Leukemic transformation disrupts this balance favoring proliferation over differentiation, but the mechanisms underlying cell cycle regulation and checkpoint control in the hematopoietic system are not understood. 5 Recent data from our laboratory has identified a unique role for the Rb tumor suppressor gene in the response to anemic and oxidative stress 6 that has implications not just for red cell production but for the homeostatic balance in the entire hematopoietic system and for the development of hematopoietic malignancies. …”
mentioning
confidence: 99%